How old is this mutation? - a study of three Ashkenazi Jewish founder mutations

被引：0
作者：
Celia MT Greenwood
Shuying Sun
Justin Veenstra
Nancy Hamel
Bethany Niell
Stephen Gruber
William D Foulkes
机构：
[1] Hospital for Sick Children Research Institute,Genetics and Genome Biology
[2] University of Toronto,Dalla Lana School of Public Health
[3] Case Comprehensive Cancer Center,General Medical Sciences (Oncology)
[4] University of Western Ontario,Department of Statistics and Actuarial Science
[5] Research Institute of the McGill University Health Centre,Department of Medical Genetics
[6] Massachusetts General Hospital,Diagnostic Radiology
[7] University of Michigan School of Public Health,Cancer Genetics, Departments of Oncology and Human Genetics, Gerald Bronfman Centre for Clinical Research in Oncology
[8] McGill University,Lady Davis Institute for Medical Research
[9] Jewish General Hospital,undefined
来源：
BMC Genetics | / 11卷
关键词：
Credible Interval; Founder Mutation; Recent Common Ancestor; Gene Genealogy; Coalescent Time;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
相关论文
共 31 条
  • [11] Recurrent and founder mutations in the Netherlands—Phospholamban p.Arg14del mutation causes arrhythmogenic cardiomyopathy
    P. A. van der Zwaag
    I. A. W. van Rijsingen
    R. de Ruiter
    E. A. Nannenberg
    J. A. Groeneweg
    J. G. Post
    R. N. W. Hauer
    I. C. van Gelder
    M. P. van den Berg
    P. van der Harst
    A. A. M. Wilde
    J. P. van Tintelen
    Netherlands Heart Journal, 2013, 21 : 286 - 293
  • [12] Ashkenazi Parkinson’s disease patients with the LRRK2 G2019S mutation share a common founder dating from the second to fifth centuries
    Anat Bar-Shira
    Carolyn M. Hutter
    Nir Giladi
    Cyrus P. Zabetian
    Avi Orr-Urtreger
    neurogenetics, 2009, 10 : 355 - 358
  • [13] Recurrent and founder mutations in the Netherlands-Phospholamban p.Arg14del mutation causes arrhythmogenic cardiomyopathy
    van der Zwaag, P. A.
    van Rijsingen, I. A. W.
    de Ruiter, R.
    Nannenberg, E. A.
    Groeneweg, J. A.
    Post, J. G.
    Hauer, R. N. W.
    van Gelder, I. C.
    van den Berg, M. P.
    van der Harst, P.
    Wilde, A. A. M.
    van Tintelen, J. P.
    NETHERLANDS HEART JOURNAL, 2013, 21 (06) : 286 - 293
  • [14] Ashkenazi Parkinson's disease patients with the LRRK2 G2019S mutation share a common founder dating from the second to fifth centuries
    Bar-Shira, Anat
    Hutter, Carolyn M.
    Giladi, Nir
    Zabetian, Cyrus P.
    Orr-Urtreger, Avi
    NEUROGENETICS, 2009, 10 (04) : 355 - 358
  • [15] Founder mutations characterise the mutation panorama in 200 Swedish index cases referred for Long QT syndrome genetic testing
    Stattin, Eva-Lena
    Bostrom, Ida Maria
    Winbo, Annika
    Cederquist, Kristina
    Jonasson, Jenni
    Jonsson, Bjorn-Anders
    Diamant, Ulla-Britt
    Jensen, Steen M.
    Rydberg, Annika
    Norberg, Anna
    BMC CARDIOVASCULAR DISORDERS, 2012, 12
  • [16] Investigation of CYP21A2 mutations in Turkish patients with 21-hydroxylase deficiency and a novel founder mutation
    Toraman, Bayram
    Okten, Aysenur
    Kalay, Ersan
    Karaguzel, Gulay
    Dincer, Tuba
    Acikgoz, Emel Gul
    Karaguzel, Ahmet
    GENE, 2013, 513 (01) : 202 - 208
  • [17] Founder mutations characterise the mutation panorama in 200 Swedish index cases referred for Long QT syndrome genetic testing
    Eva-Lena Stattin
    Ida Maria Boström
    Annika Winbo
    Kristina Cederquist
    Jenni Jonasson
    Björn-Anders Jonsson
    Ulla-Britt Diamant
    Steen M Jensen
    Annika Rydberg
    Anna Norberg
    BMC Cardiovascular Disorders, 12
  • [18] BRCA1 mutations in South African breast and/or ovarian cancer families:: Evidence of a novel founder mutation in Afrikaner families
    Reeves, MD
    Yawitch, TM
    van der Merwe, NC
    van den Berg, HJ
    Dreyer, G
    Van Rensburg, EJ
    INTERNATIONAL JOURNAL OF CANCER, 2004, 110 (05) : 677 - 682
  • [19] The Tyr978X BRCA1 mutation:: occurrence in non-Jewish Iranians and haplotype in French-Canadian and non-Ashkenazi Jews
    Quintana-Murci, L
    Gal, I
    Bakhan, T
    Quach, H
    Sayar, SH
    Shiri-Sverdlov, R
    Baruch, RG
    McElreavey, K
    Dagan, E
    Narod, S
    Friedman, E
    FAMILIAL CANCER, 2005, 4 (02) : 85 - 88
  • [20] The Tyr978X BRCA1 mutation: occurrence in non-Jewish Iranians and haplotype in French-Canadian and non-Ashkenazi Jews
    Lluís Quintana-Murci
    Inbar Gal
    Tangiz Bakhan
    Hélène Quach
    S Hamid Sayar
    Ronit Shiri-Sverdlov
    Ruth Gershoni Baruch
    Ken McElreavey
    Efrat Dagan
    Steven Narod
    Eitan Friedman
    Familial Cancer, 2005, 4 : 85 - 88
1234